Medical Cannabis RCT for Endometriosis Pain Research
This medicinal cannabis endometriosis trial feasibility safety study tested inhaled THC flower and oral CBD oil against placebo for endometriosis pain management. The randomized controlled trial evaluated recruitment, retention, and safety outcomes in…
Digital Therapeutics for Smoking Cessation in HIV Patients
HIV smoking cessation digital therapeutics show promise in engaging people living with HIV for tobacco cessation. Clinical trial data supports feasibility and acceptability of these tools. Technology-based interventions can reach this population…
Review of Cannabinoid Clinical Trials for Anxiety and Tourette
Cannabinoid clinical trials anxiety research reveals measurable reductions in anxiety symptoms across various disorders. Evidence supports modest but meaningful benefits, especially for generalized anxiety and Tourette syndrome. These findings highlight…
Understanding Cannabis Induced Psychosis and Schizophrenia Progression
Cannabis induced psychosis schizophrenia progression is a critical area of study for understanding long-term psychiatric risks. Patients with cannabis induced psychosis often face increased chances of developing schizophrenia spectrum disorders. Early…
Exploring Endocannabinoid System and Adolescent Psychiatric Risk
Endocannabinoid system adolescent psychiatric risk is a critical area of study linked to cannabis use in teens. Research shows increased risk of psychotic, bipolar, depressive, and anxiety disorders. Understanding this risk helps guide clinical practice…
Endocannabinoid System Research: Teen Cannabis Intervention
Sequential cannabis prevention messaging offers a promising approach to reduce cannabis use among adolescents. This strategy tailors messages to teens' beliefs and norms, improving engagement. Research shows it effectively lowers cannabis use intentions…
CBD Autism Trial: Endocannabinoid System Clinical Research
This cannabidiol autism anxiety clinical trial study evaluated oral CBD oil effects on autistic children aged 5 to 12. The randomized controlled crossover trial measured social relating, anxiety, and parental stress outcomes. Results suggest potential…
Clinical Evidence on GLP-1 Receptor Agonists and Mental Health
Glucagon-like peptide-1 receptor agonists mental health effects were studied using genetic methods to assess their impact on psychiatric conditions. Evidence suggests these drugs may influence risk for schizophrenia and substance use disorders.…
Endocannabinoid System Research: Cannabis & Child Development
Peripregnancy cannabis exposure is linked to behavioral and developmental differences in children, with varying effects based on autism spectrum disorder symptoms. This research highlights the importance of understanding maternal cannabis use during…
Review of Cannabinoid Clinical Trials in Mental Health and Substance Use Treatment
Cannabinoid clinical trials mental health substance use treatment research remains limited and inconclusive. Current randomized controlled trials have not firmly established cannabinoids as effective or safe primary treatments. Clinicians should…